Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients

BACKGROUND: Bone and soft tissue sarcomas (BSTS) are rare malignant tumors. Recently, the combination of gemcitabine and docetaxel (GD) was shown to have activity as second-line setting in BSTS. However, the efficacy as first-line and adjuvant settings and precise profiles of adverse events in Japan...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Kazuhiro, Joyama, Susumu, Chuman, Hirokazu, Hiraga, Hiroaki, Morioka, Hideo, Yoshikawa, Hideki, Hosaka, Masami, Takahashi, Mitsuru, Kubo, Tadahiko, Hatano, Hiroshi, Kaya, Mitsunori, Toguchida, Junya, Nishida, Yoshihiro, Nagano, Akihito, Tsumura, Hiroshi, Iwamoto, Yukihide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146834/
https://www.ncbi.nlm.nih.gov/pubmed/27931230
http://dx.doi.org/10.1186/s12957-016-1059-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146834/
https://www.ncbi.nlm.nih.gov/pubmed/27931230
http://dx.doi.org/10.1186/s12957-016-1059-2

Ejemplares similares